The U.S. Food and Drug Administration (FDA) issued a Safety Communication today reminding consumers and health care providers that currently authorized SARS-CoV-2 antibody tests should not be used to evaluate a person’s level of immunity or protection from COVID-19.
SARS-CoV-2 antibody tests help identify whether someone has antibodies to SARS-CoV-2, the beta coronavirus that causes COVID-19, indicating a prior virus infection.
The FDA stated on May 19, 2021, these antibody test results can be misinterpreted, especially after the person received a COVID-19 vaccination.
Read More
